Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 7 EP applications Julie Frances Reeves has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after January 16, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12822519

ANTIOXIDANT TOPICAL COMPOSITIONS

IPC classification:
A61K 8/34, A61K 8/67, A61K 9/12, A61P 17/00, A61Q 19/00, A61Q 19/08
Agent:
Julie Frances Reeves, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP15151851

Dispensers for Tissue Dilator Devices

IPC classification:
A61F 5/08, A61F 13/00, A61F 13/12, A61F 15/00, B65H 5/28, G07F 11/66
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14754670

NON-AQUEOUS SOLID STABILIZED EMULSIONS

IPC classification:
A61K 8/04, A61K 8/25
Agent:
Julie Frances Reeves, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP14714047

DYE FREE LIQUID THERAPEUTIC SOLUTION

IPC classification:
A61K 9/08, A61K 31/167, A61K 47/10, A61K 47/26
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP14795047

NICOTINE LOZENGE FORMULATION

IPC classification:
A61K 9/20, A61K 31/465
Applicant:
GlaxoSmithKline LLC
Agent:
Julie Frances Reeves, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP15767328

TOPICAL DICLOFENAC SODIUM COMPOSITIONS

IPC classification:
A61K 9/00, A61K 9/06, A61K 9/107, A61K 31/196, A61P 19/02, A61P 29/00
Agent:
Julie Frances Reeves, GlaxoSmithKline
Status:
Request for examination was made
EP15858701

PROBIOTIC THERAPEUTIC APPLICATIONS

IPC classification:
A61K 35/74, A61P 11/00
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Julie Frances Reeves, GlaxoSmithKline
Status:
Request for examination was made

Please Sign in to use this feature